GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sun Pharma Advanced Research Company Ltd

SPARC: Dr. Shravanti Bhowmik resigns; Narendra Lakkad appointed Head Corporate Development

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 Mar 2026, 06:42 PM IST  ·  BSE ID: e8840f1b-9b1a-4ab5-8429-8222c55ae255
View Original BSE Filing (PDF)
💡
In Simple Terms
The company replaced its operations head with an internal veteran who previously worked at SPARC and Sun Pharma for three decades.
🤖 AI Summary
  • Dr. Shravanti Bhowmik resigned as Vice President, Operations Management effective March 31, 2026
  • Narendra Lakkad appointed Head—Corporate Development and Operations Management effective April 01, 2026
  • Lakkad holds Master's degree in Pharmacology; 32-year tenure with Sun Pharma group since 1994
  • Board approval via circular resolution March 27, 2026 on Nomination and Remuneration Committee recommendation
🔢 Key Numbers - exact figures from BSE filing, not rounded
Resignation effective date
March 31, 2026
New appointment effective date
April 01, 2026
Narendra Lakkad tenure in Sun Pharma group
Since 1994 (32 years)
Prior SPARC tenure (Lakkad)
2014-2018
🏢 How This Affects the Company
⚙️
Operational Impact
Operations Management leadership transition from Bhowmik to Lakkad consolidates corporate development and operations under single executive. Lakkad brings 32-year Sun Pharma group experience and prior SPARC tenure, potentially ensuring continuity in operations and business development functions.
👥 What This Means For Shareholders
✅
Action Required
No action required. Monitor Q1 FY27 business updates for operational continuity confirmation.
👤
Who Is Affected
All shareholders. No specific shareholder class affected by this management transition.
🔍
Management Signal
Board prioritized operational continuity by appointing internally experienced candidate with established Sun Pharma group relationships and prior SPARC role knowledge.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q1 FY27 operational metrics—confirm no disruption in business development or operations execution
Annual Report FY26—assess organizational structure changes and management commentary on transition impact
Next investor presentation—track corporate development pipeline and alliance management progress under Lakkad leadership
LOW RISK Internal successor with 32-year group experience and prior SPARC tenure mitigates transition risk. No indication of operational disruption.
💡 Investor Takeaway
Routine senior management change: operations head departure balanced by appointment of 32-year Sun Pharma veteran with prior SPARC corporate development and alliance management experience. Internal successor provides operational continuity.
⚖️ Strengths & Concerns

✅ Positives

  • Incoming Head brings 32-year Sun Pharma group experience and prior SPARC tenure (2014-2018) in corporate development roles
  • Internal appointment with proven track record in business development, investor relations, and alliance management across group entities
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel